BNP Paribas Financial Markets’s NexImmune, Inc. Common Stock NEXI Stock Holding History

BNP Paribas Financial Markets’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-41	Closed	-$113	–	4287
2024 Q2	$113	Hold	41	–	–	﹤0.01%	3963
2024 Q1	$230	Buy	+41	New	+$316	﹤0.01%	3938
2022 Q4	–	Sell	-54	Closed	-$748	–	4756
2022 Q3	$748	Buy	+54	New	+$1.58K	﹤0.01%	4476

Other funds holding NEXI

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BNP Paribas Financial Markets's NEXI Position: Q3 2024 in Review

BNP Paribas Financial Markets sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2024, closing a stake of 41 shares — an estimated $113 sold.

BNP Paribas Financial Markets first reported a position in NEXI in Q3 2022 and held it in 3 quarters. The position peaked at $748 in Q3 2022. 1 fund tracked by Wall St. Rank holds NEXI as of Q3 2024.

BNP Paribas Financial Markets reported no remaining NexImmune, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
BNP Paribas Financial Markets sold 41 NexImmune, Inc. Common Stock shares in Q3 2024, an estimated $113.
BNP Paribas Financial Markets first reported a position in NexImmune, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
BNP Paribas Financial Markets's NexImmune, Inc. Common Stock position peaked at $748 in Q3 2022.
1 fund tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2024.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2024, filed 13 Nov 2024.